BioCentury
ARTICLE | Clinical News

Novastan: TXB started an open label Phase III trial

May 13, 1996 7:00 AM UTC

Patients will receive a bolus of 350 µg/kg of Novastan followed by an infusion of up to 40 µg/kg/minute of drug. The starting infusion dose is 25 µg/kg/minute. Patients will be compared with a histori...